Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 23;12:10541–10550. doi: 10.2147/CMAR.S268863

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Guo et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

MiR-520d-3p silence abolishes the effect of USP2-AS1 down-regulation on ovarian cancer cell proliferation, apoptosis and migration. (A) The impact of miR-520d-3p inhibition on the proliferation of USP2-AS1-silence cells was determined by EdU assay. (B and C) TUNEL and JC-1 assays evaluated whether miR-520d-3p inhibitor could regulate the apoptosis of USP2-AS1-depleted A2780 and SKOV3 cells. (D) Transwell assay assessed the migration ability of A2780 and SKOV3 cells transfected with sh-NC, sh-USP2-AS1#1 or sh-USP2-AS1#1+ miR-520d-3p inhibitor. **P<0.01.